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Abstract
Widespread metastasis is the major cause of death from melanoma and other types of cancer. At present, the dynamic aspects of the
metastatic cascade remain enigmatic. The feasibility to track circulating melanoma cells deep within living intact organisms can
greatly impact our knowledge on tumor metastasis, but existing imaging approaches lack the sensitivity, spatio-temporal resolution
or penetration depth to capture flowing tumor cells over large fields of view within optically-opaque biological tissues. Vast progress
with the development of optoacoustic tomography technologies has recently enabled two- and three-dimensional imaging at
unprecedented frame rates in the order of hundreds of Hertz, effectively mapping up to a million image voxels within a single vol-
umetric snapshot. Herein, we employ volumetric optoacoustic tomography for real-time visualization of passage and trapping of
individual B16 melanoma cells in the whole mouse brain. Detection of individual circulating melanoma cells was facilitated by sub-
stituting blood with an artificial cerebrospinal fluid that removes the strong absorption background in the optoacoustic images. The
approach can provide new opportunities for studying trafficking and accumulation of metastatic melanoma cells in different organs.
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Introduction
Malignant melanomas are very aggressive tumors responsible for almost
60% of deaths from skin cancer [1]. Melanomas originate from trans-
formed melanocytes, which are pigment-producing cells present in the
skin of humans and other mammals [2]. Melanoma cells tend to detach
from the primary tumor and enter the bloodstream to become highly inva-
sive and metastatic at secondary sites in the body [3]. To this end, signif-
icant efforts have been invested into studying the steps involved in
metastasis, yet this process remains one of the most enigmatic aspects of
cancer progression [4]. One major reason behind this knowledge gap is
lack of suitable imaging tools capable of visualizing dynamic biological
processes deep in an intact living organism with sufficient spatio-
temporal resolution [5]. Since tumors mainly disseminate through the
bloodstream, major advancement with development of new therapeutic
strategies can be made by enabling direct observation of how tumor cells
enter the vessels, extravasate in distant areas, adapt to new environments,
eventually seeding and proliferating [6]. Tumor cells flowing within vascu-
lar structures are known as circulating tumor cells (CTCs). The latter have
been studied as minimally invasive multifunctional bio-markers with
promising prognostic value [7]. Indeed, reliable detection of CTC pres-
ence in blood may serve as a more reproducible indicator of disease status
as compared to macroscopic tumor observations with conventional clinical
imaging modalities, at least in some types of cancer [8]. Imaging of CTCs
is technically challenged by the low sensitivity in detecting these rare cells
in deep tissues. Even though melanin is a paramagnetic substance gener-
ating contrast in magnetic resonance imaging (MRI) [9,10], labelling is
generally required to track cellular dissemination [11]. Additionally, CTCs
have relatively large size with respect to the bores of capillaries and are
expected to mainly trap in the capillary bed during the first pass [4].
Thereby, high-frame-imaging is required to capture their dynamics in
blood and better understand their in vivo behavior.
Optoacoustic (OA) tomography has recently been advanced to attain
ultrafast two- and three-dimensional imaging at rates of hundreds to thou-
sands of frames per second [12–14]. By further capitalizing on its unique
optical absorption contrast, OA has provided unprecedented insights into
rapid biological processes, such as whole brain activity or cardiovascular
dynamics [13,15,16]. The feasibility to detect primary melanomas and cir-
culating melanoma cells by exploiting the endogenous contrast generated
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by melanin has been demonstrated with early OA embodiments [17,18].
Cell labeling, magnetic trapping and proper selection of the detection
bandwidth have subsequently facilitated more sensitive detection of flow-
ing CTCs [19–22]. To this end, single cells can readily be detected with
OA microscopy at shallow depths [23,24], while tomographic approaches
have also been shown capable of resolving individual melanin-loaded cells
[25]. Yet, dynamic visualization of individual flowing CTCs in large tissue
volumes has not been achieved so far.
Herein, we employed volumetric OA tomography to dynamically track
circulating melanoma cells at an imaging rate of 100 volumes per second
and 200 mm spatial resolution across a field of view of 1 cm3. The
imaging scanner was combined with a cardiac perfusion system that sub-
stituted blood with an artificial cerebrospinal fluid (ACSF) to reduce the
background light absorption and enable efficient detection of single cells.
We then capitalized on the high sensitivity and spatio-temporal resolution
of the OA tomography system to visualize how intracardially-injected B16
melanoma cells flow through the cerebral circulatory system and subse-
quently lodge in capillaries.
Results
Single-cell imaging in phantoms
The feasibility to detect OA signals generated by individual B16 mela-
noma cells and distinguish those in the OA images was first demonstrated
by embedding sparsely distributed cells in an agar phantom. Lay-out of the
experimental system is schematically depicted in Fig. 1a (see methods for a
detailed description). Basically, the output light beam of a tunable optical
parametric oscillator (OPO)-based laser was guided through a fiber bundle
to illuminate an area of 4 mm diameter on the surface of the phantom
(optical fluence <20 mJ/cm2). The generated OA signals were detected
with a custom-made 512-element spherical array coaxially aligned with
the fiber bundle, which provides an almost isotropic resolution of
150 lm around the center of the sphere [26]. The volume enclosed
between the phantom and the array surface was filled with agar to guarantee
acoustic coupling. Fig. 1b shows the maximum intensity projection (MIP)
along the depth direction of the reconstructed 3DOA image corresponding
to excitation with a single laser pulse at 700 nm. The image exhibited a
signal-to-noise ratio (SNR) of 22, calculated as the average intensity of 5
detectable dots relative to the standard deviation in a background region.
A bright field microscopy image taken after OA imaging (Fig. 1c) was used
to look through the entire agar layer and identify individual melanoma
cells. Note that the OA resolution is inferior to the bright field images,
hence the observed dots are significantly larger. Yet, the central positions
of the dots match the positions of the isolated cells in the bright field image.
This, along with the high SNR of the OA image, serves to verify that indi-
vidual cells can be clearly detected and resolved. This is expected consider-
ing that B16 melanoma cells are large melanin-loaded cells with typical
dimensions of 30 lm (inset in Fig. 1c). No significant photodamage
associated to laser exposure was observed in the cells.
The basic capability to track flowing cells was additionally demon-
strated with the same imaging set-up by embedding polyethylene tubing
with 0.58 and 0.96 mm inner and outer diameters, respectively (Smiths
Medical Inc. Minneapolis, USA), in agar and operating the laser at
100 Hz pulse repetition frequency (PRF). In order to mitigate image
intensity fluctuations, the acquired signals were further normalized with
the per-pulse laser photodiode energy readings provided by the laser.
Fig. 1d shows a representative 3D view of the OA images acquired at
700 nm excitation wavelength for two consecutive time instants. Consid-
ering that the B16 cell solution was filtered with 35 mm mesh size before
injection into the tubing, the dots in Fig. 1d clearly represent individual
cells. In a practical scenario, the OA signal from melanoma cells is mixed
with a background signal mainly generated by blood. Fig. 1e displays the
extinction coefficients of melanin and hemoglobin for different oxygen
saturation (sO2) levels. The ratio of extinction coefficients is shown in
Fig. 1f, also as a function of sO2. Black dots indicate the maxima of each
curve. It is shown that the highest ratio is achieved for 680 nm at
sO2 = 100% while it converges to 730 nm at lower sO2 levels. Consid-
ering typical sO2 levels of 98% and 70% in arteries and veins, respectively,
it appears that shorter wavelengths in the NIR window are more suitable
for detecting circulating cells in the presence of blood. However, the light
attenuation gets stronger at shorter wavelengths due to higher photon
absorption and scattering, which needs to be taken into account when
aiming at deep tissue penetration. Melanin may also be spectroscopically
unmixed from OA images taken at multiple wavelengths. However, mel-
anin features a monotonically decreasing absorption spectrum without dis-
tinctive peaks, which hampers its accurate unmixing. This range of
wavelengths appears also to be appropriate to detect the cells in capillary
networks featuring sO2 values below 50% [27,28].
Cell tracking in mouse brain
An intracardially perfused mouse model was developed to physically
remove the highly absorbing background of mammalian tissues and facil-
itate the detection of melanoma cells. Substitution of blood by oxygenated
ACSF delivered at pressures of 100 þ 2 mmHg and physiological body
temperature of 37 þ 0.5 C enabled preserving functional activity resem-
bling in vivo conditions for up to 45 min [29]. The perfusion and imag-
ing set-up is sketched in Fig. 2a (see methods for a detailed description).
OA images of the mouse brain were acquired during the entire perfusion
procedure with the output wavelength and PRF of the laser set to 700 nm
and 100 Hz, respectively. As expected, the background OA signal at the
discernible vascular structures dropped significantly following perfusion
(Fig. 2b), even though it appears that some blood tends to accumulate
in the frontal part of the superior sagittal sinus. The perfusion procedure
is best visualized in a movie showing the top-view MIPs of the recon-
structed OA volumes provided in the on-line version of the journal (sup-
plementary movie 1).
The feasibility to track B16 melanoma cells in the brain vascular net-
work was demonstrated by filtering the B16 buffer (mesh size 35 mm)
before injection through the 25 G butterfly needle inserted in the left ven-
tricle. A total volume of 1000 ll containing approximately 2.5 million cells
was injected. OA imaging was performed with the laser wavelength and
PRF set to 700 nm and 50 Hz, respectively. Representative OA images
(MIPs of the reconstructed 3D OA images along the depth direction) for
several time points after injection of the melanoma cells are shown in
Fig. 3a. The background signal levels in these images was rescaled with
respect to Fig. 2b. Flowing cells are labelled with arrows, while stars repre-
sent cells that have been arrested in microvascular structures. The flow of
cells is further illustrated in the top-view MIPs (supplementary movie 2)
and rotating-view MIPs (supplementary movie 3) videos accompanying
the on-line version of the manuscript. Fig. 3b displays the OA image
(MIP along the depth direction) obtained after subtracting the average of
100 frames before cell injection for a time point when circulation of cells
was no longer detected. In this way, signals originating from the cells can
be effectively amplified via background removal. This approach may facil-
itate the visualization of cells in vivo. However, inter-frame motion of
microvascular structures ascribed to respiratory and cardiac cycles as well
as per-pulse laser fluctuations (in energy and beam shape) represent addi-
tional significant challenges. The resulting image obtained after back-
ground subtraction has an SNR of 19, calculated as the average intensity
of the five labelled dots normalized by the standard deviation in the back-
ground region. This is consistent with the SNR values obtained in the
phantom experiments considering the light attenuation associated with tis-
442 Deep tissue volumetric optoacoustic tracking X. L. Deán-Ben et al. Neoplasia Vol. 22, No. 9, 2020
sue absorption and scattering in the scalp and skull of the mouse. Two
videos showing the MIPs of background-subtracted frames along with
the reference anatomical image taken before intracardiac perfusion are also
available in the on-line version of the journal (supplementary movie 4 and
5). Several B16 cells arrested in the cortical microvasculature were visible in
the photograph of excised brain taken after the experiment (Fig. 3c). Their
relative locations match the positions of the dots detected in the OA image
(labelled with arrows in Fig. 3b and c). Microscopic images of the cells
marked in Fig. 3c are displayed in Fig. 3d. Those represent individual mel-
anoma cells that were lodged in a superficial region accessible with optical
microscopy. Other detected dots in the OA image may also represent indi-
vidual cells, although melanoma cells can also circulate as microclusters.
Fig. 1. Optoacoustic imaging of isolated cells. (a) Lay-out of the optoacoustic imaging system. M – B16 melanoma cells, LB – laser beam, UW –
ultrasound waves, TA – transducer array. (b) Maximum intensity projection (MIP) of the three-dimensional optoacoustic image of isolated melanoma
cells in agar. Scalebar – 1 mm. (c) Equivalent bright field microscopic image of the cells. Scalebar – 50 lm. (d). Three dimensional view of the
optoacoustic images acquired at two consecutive instants for B16 cells flowing in a tubing. Scalebar – 2 mm. (e) Molar extinction coefficient (absorption
spectrum) of melanin and hemoglobin as a function of the oxygen saturation (sO2) level. (f) Ratio of the extinction coefficients in (e) as a function of sO2.
Fig. 2. Blood removal via intracardial perfusion. (a) Lay-out of the intracardiac perfusion model along with the optoacoustic imaging system. TA –
transducer array, PT – pressure transducer, HC – heating coil, ACSF – artificial cerebrospinal fluid. (b) Maximum intensity projections (MIPs) of the
three dimensional optoacoustic images taken before (left) and after (right) ACSF perfusion along with boxplots of the optoacoustic signals for the 100
brightest voxels in the image as a function of time. Scalebar – 3 mm.
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Discussion
The ability to follow the distribution and migration of metastatic cells
is of vast importance for elucidating biological processes involved in tumor
metastasis. To this end, the metastatic steps have been classified in two
major phases, namely, physical translocation of cells from the primary
tumor to a new microenvironment in distant tissues and cell proliferation
and formation of a secondary tumor (colonization) [4]. The approach sug-
gested herein offers the unprecedented capability to visualize the dynamics
of cell transportation in entire macroscopic three-dimensional regions,
providing new insights on how cells migrate and invade new tissues. From
a clinical point of view, a better understanding of physical translocation of
cells may find utility in preventing metastasis in patients diagnosed at an
early stage and potentially define new therapeutic strategies in patients in
which metastatic dissemination has been detected. Generally, the presence
of cancer cells in the draining lymph nodes is the first indicator of metas-
tasis. Metastatic melanoma cells have previously been observed with OA
tomography in human sentinel lymph nodes at centimeter-scale depths
[30]. Moreover, longitudinal tracking of tumor xenografts composed of
cells synthesizing eumelanin via expression of tyrosinase has been per-
formed with a high resolution OA imaging system [31].
The demonstrated feasibility to track B16 melanoma cells in the mouse
brain allows addressing the critical question of whether volumetric OA
tomography has sufficient sensitivity to detect flowing cells in living organ-
isms. Yet, in our current experiments the blood was removed from the cir-
culation while relatively large and highly-absorbing cells were employed.
Visualizing the B16 melanoma cells in an intact animal can be made feasi-
ble if the blood background in the OAT images is eliminated to effectively
amplify the signals from the cells. Spectral or temporal un-mixing
approaches may aid this purpose [32–34], but challenged by pulse-to-
pulse laser fluctuations and highly non-uniform light distribution in living
tissues. Using higher frequency ultrasound arrays tailored to imaging of
microvascular structures containing less blood than major vessels can also
facilitate single cell detection [25]. Once the ultimate goal of tracking indi-
vidual melanoma cells in deep tissues in the presence of blood is accom-
plished, the adaptation of the arrested cells to the new microenvironment
and the growth of the secondary tumor can be studied in unperturbed
in vivo environment. The observation of the initial colonization steps is
challenged by the inefficiency of this process, since most of the cells expe-
rience apoptosis after extravasation or stay dormant for long periods of time
[4]. It may also be possible to observe how cells intravasate the microvascu-
lature of the lymph and blood systems, which is also an unlikely event to be
captured. Detection of cells that are smaller or less absorbing than mela-
noma cells is additionally challenged by their lower OA detection thresh-
olds. In general, the amplitude of the OA signals generated by a cell is
proportional to the amount of light being absorbed, which generally scales
with the cell volume, so that labelling may be required as in standard cell-
tracking methods based on light microscopy [35]. Cell tracking is highly
important for determining the distribution and long-term viability of bio-
logically active cell populations in novel cancer therapeutic approaches such
as adoptive immunotherapy or stem-cell therapy [36]. Cancer stem cells
(CSC) appear to play an important role in cancer metastasis, which may
be better understood if the dynamics of migration and differentiation of
these cells can be effectively captured with a non-invasive high-resolution
imaging modality. At a technical level, the demonstrated feasibility to
detect individual absorbers flowing in vascular networks may find further
use for enhancement of visibility and resolution of OA images via super-
resolution and localization-based approaches [37–40].
All in all, optical methods based on endogenous or exogenous contrast
are essential tools for unfolding the complex biological dynamics involved
in cancer progression. While optical microscopy can resolve cellular and
sub-cellular structures with high spatial resolution, the latter quickly dete-
riorates with depth due to light scattering in biological tissues. OA tomog-
raphy has enabled breaking through this light diffusion limit by delivering
high-resolution imaging of tumors at a whole-body scale in rodents [41–
43]. Moreover, sub-micron spatial resolution in OA imaging can be
achieved at <1 mm depths via optical focusing or using ultra-high-
bandwidth ultrasound detectors [23,24], thus complementing information
provided by fluorescence microscopy at the cellular level. Thereby, OA
operates at a myriad of spatial scales ranging from organelles to organs with
Fig. 3. Tracking of B16 cells in the mouse brain. (a) Maximum intensity projections (MIPs) of the three-dimensional optoacoustic images. Scalebar –
2 mm, t0 indicates the time point when injection is started. (b) MIP of the optoacoustic image after background substraction (hot colormap) along with
the MIP of the optoacoustic image before intracardiac perfusion (gray colormap). (c) Photograph of the excised brain for the green region indicated in (b).
(d) Microscopic images of the red and blue regions indicated in (c) containing individual cells.
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a very versatile optical-absorption-based contrast [44]. Additionally, bio-
logical dynamics at multiple temporal scales ranging from milliseconds
to hours or days can be covered with the method [45]. This unique capac-
ity of optoacoustics may enable a more comprehensive view of cancer pro-
gression at spatial and temporal scales not covered by other modalities,
with potential applicability in the clinical setting.
Methods
Optoacoustic imaging system
The spherical array (Imasonic SaS, Voray, France) used for optoacous-
tic tomographic imaging of the mouse brain was previously described [26].
Briefly, it consists of 512 piezocomposite elements densely distributed on
a spherical surface with 40 mm radius and 140 (1.3p solid angle) angular
coverage. Individual elements have 5 MHz central detection frequency
and 100% 6 dB bandwidth. The array features a central cylindrical aper-
ture with 8 mm diameter where light is delivered through a custom-made
fiber bundle (Ceramoptec GmbH, Bonn, Germany). The output of an
optical parametric oscillator (OPO) laser (Innolas GmbH, Krailling, Ger-
many) providing 25 mJ (12 mJ at the output of the fiber bundle),
<10 ns laser pulses at pulse repetition frequencies (PRFs) up to 100 Hz
was coupled into the fiber. The wavelength of the laser can be tuned in
the 700–900 nm range in a per-pulse basis. For animal imaging, the vol-
ume enclosed between the mouse head and the detection surface of the
array was filled with agar. The agar block featured a cylindrical cavity coax-
ially aligned with the fiber bundle, which was filled with water to acous-
tically couple the mouse skin and reduce the light attenuation within
agar. The beam diameter at the tissue surface was 8 mm, resulting in
laser fluence <20 mJ/cm2.
Intracardiac perfusion model
The intracardiac perfusion model was based on a recently-developed
protocol [29]. Basically, intracardiac perfusion was performed after
intraperitoneal (IP) injection of a mixture of 87.5 mg/kg Ketamine (Bre-
mer Pharma, Wabing, Germany) and 12.5 mg/kg Xylazine (Bela-pharm,
Vechta, Germany). 75 U of Heparin (Ratiofarm GbmH, Ulm, Germany)
diluted in 100 ml 0.9% NaCl Solution (Braun AG, Melsungen, Ger-
many) was also injected IP. The mouse was placed in supine position upon
a silicon sheet with all extremities fixed with needles (Fig. 2a) and with the
head fixed to a custom-made stereotactic holder (Narishige International
Limited, London, UK). A second (lethal) dose of 87.5 mg/kg Ketamine
and 12.5 mg/kg Xylazine was then injected IP. Access to the heart was
ensured via removal of the ventral portion of the rib cage with an incision
from the mid abdomen to the sternum. Freshly prepared artificial cere-
brospinal fluid (ACSF) was supplied with Carbogen (Linde Group,
Munich, Germany) and kept inside a Haake S7 water bath (ThermoFisher
scientific Messtechnik GmbH, MÏnchen, Germany) set to 42 C. A
PLP3S perfusion pump (Bohr Labortechnik, DÏsseldorf) was used to
transfer ACSF at a rate of 4.5–6 ml/min from its heated receptacle through
a bubble trap, a glass heating coil (Radnoti LTD, Dublin, Ireland) and a
physiological pressure transducer (AD Instruments, Sydney, Australia)
connected to a pressure transducer Simulator/Tester (Utah Medical Prod-
ucts, Midvale, UT, USA). The flow continued through a 25G butterfly
needle inserted in the left ventricle at an output temperature of 36.5–
37.5 C, while the right atrium was opened with an incision. The pressure
of the pulsatile perfusion procedure was maintained below the physiolog-
ical maximum of 100 mmHg by adjusting the pump rate. ACSF was
pumped through the setup for at least 2 minutes before needle placement
to remove any air bubbles within the set-up. After removal of blood via
ACSF perfusion, the cells were added to the ACSF flow through a stop-
cock (Braun, Melsungen, Germany) via manual injection. All the animal
experiments were carried out in accordance with the regulations of the
Helmholtz Center Munich and with approval from the Government Dis-
trict of Upper Bavaria.
Cell culture and preparation
B16F10 murine melanoma cells were cultured in DMEM (Sigma-
Aldrich) growth media supplemented with 10% fetal bovine serum and
1% Penicillin/Streptomycin and kept at 37C and 5% CO2. The cell lines
were regularly checked for mycoplasma contamination and authenticity.
For experimentation, an early cell passage was used to ensure strong intra-
cellular melanin accumulation. Cells were detached using Trypsin/EDTA
and washed twice with PBS buffer. Repeated gentle pipetting of cells as
well as straining through a 35 mm mesh prior to injection in a PBS/2mM
EDTA solution ensured single cell events. The average cell size of B16F10
was 16 mm as determined by the Countess Cell counter (Thermo Fisher
Scientific, Waltham, Massachusetts, USA). 2.5 million cells diluted in
1 ml solution were intracardially injected in the mouse. This large amount
of cells, much higher than typical concentrations of 1–10 cells/ml in vivo
[46], was considered to ensure that circulating cells were detected in the
limited region of interest covered by the three-dimensional OA imaging
system.
Optical microscopic imaging of the isolated brain
The mouse brain was extracted (isolated) after the experiment. For this,
an incision in the skull was performed with bone scissors and the upper
skull plate, together with the brain, was carefully removed with forceps.
The brain was carefully isolated with forceps in a Petri dish filled with
ice-cold, oxygenated ACSF. Bright field images of the extracted brain were
taken with Dino-Lite USB Mikroskop AD7013MZT (2592  1944
Pixel). Additionally, microscopic images with sub-cellular resolution of
the arrested cells with higher magnification were taken on a Leica DMI
3000B inverted microscope with C Plan L40x/0.50 PH2 and
L20x/0.40 objectives. The Leica application suite software was used to
acquire the images. Due to their strong black contrast, the injected
B16F10 cells were easily detectable before the white brain background.
The unperturbed whole brain was imaged, thus facilitating the visualiza-
tion of cells closer to the brain surface.
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